CNTB
Connect Biopharma Holdings LtdNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$132.22M
P/E Ratio
—
EPS
$-1.15
Beta
-0.18
52W High
$3.82
52W Low
$0.91
50-Day MA
$2.50
200-Day MA
$2.31
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
0.77
PEG Ratio
—
About Connect Biopharma Holdings Ltd
Connect Biopharma Holdings Limited, a clinical-stage biopharmaceutical company, is focused on the discovery and development of immune modulators for the treatment of severe autoimmune diseases and inflammation. The company is headquartered in Taicang, China.
Fundamentals
| Revenue (TTM) | 233,000 |
| Gross Profit (TTM) | 233,000 |
| EBITDA | $-65.54M |
| Operating Margin | -11602.00% |
| Return on Equity | -102.90% |
| Return on Assets | -54.20% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $0.68 |
| Price-to-Book | 3.10 |
| Price-to-Sales (TTM) | 567.49 |
| EV/Revenue | 372.89 |
| EV/EBITDA | 0.19 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | -100.00% |
| Shares Outstanding | $62.96M |
| Float | $18.86M |
| % Insiders | 31.82% |
| % Institutions | 54.26% |
Historical Volatility
HV 10-Day
67.40%
HV 20-Day
65.22%
HV 30-Day
74.17%
HV 60-Day
86.62%
HV Rank
—
Volatility is currently contracting
Analyst Ratings
Consensus ($7.07 target)
7
BuyMore HEALTHCARE Stocks
Data last updated: 6/13/2026